deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT03448549

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

A Prospective Randomized Controlled Trial to Compare Oxaliplatin Combined With S-1 (SOX) Versus Oxaliplatin With Capecitabine (XELOX) as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions Adjuvant Chemotherapy Colorectal Cancer Stage III
Interventions Oxaliplatin Tegafur，gimeracil and oteracil potassium Xeloda
Updated 10 times since 2018 Last updated: Mar 5, 2020 Started: Jan 1, 2018 Primary completion: Jan 1, 2021 Completion: Jan 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Adjuvant Chemotherapy and Colorectal Cancer Stage III, this trial is ongoing. The trial is conducted by Cancer Institute and Hospital, Chinese Academy of Medical Sciences and has accumulated 10 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotRecruiting~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotRecruiting~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshotRecruiting~Aug 2018 – ~Apr 2020 · 20 months · monthly snapshotRecruiting~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotRecruiting~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotRecruiting~Nov 2022 – ~Feb 2024 · 15 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Feb 2024 — Jul 2024 [monthly]

    Unknown Status PHASE3

    Status: Recruiting → Unknown Status

  4. Nov 2022 — Feb 2024 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — Nov 2022 [monthly]

    Recruiting PHASE3

▶ Show 5 earlier versions

  1. Apr 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  2. Aug 2018 — Apr 2020 [monthly]

    Recruiting PHASE3

  3. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

  4. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE3

  5. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences
  • Peking Union Medical College Hospital
  • Peking University Cancer Hospital & Institute
  • Peking University People's Hospital
Data source: Peking University Cancer Hospital & Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations